BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38308802)

  • 1. Utility of contrast-enhanced MRI radiomics features combined with clinical indicators for predicting induction chemotherapy response in primary central nervous system lymphoma.
    Wang X; Zhao L; Wang S; Zhao X; Chen L; Sun X; Liu Y; Liu J; Sun S
    J Neurooncol; 2024 Feb; 166(3):451-460. PubMed ID: 38308802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics-based differentiation between glioblastoma and primary central nervous system lymphoma: a comparison of diagnostic performance across different MRI sequences and machine learning techniques.
    Bathla G; Priya S; Liu Y; Ward C; Le NH; Soni N; Maheshwarappa RP; Monga V; Zhang H; Sonka M
    Eur Radiol; 2021 Nov; 31(11):8703-8713. PubMed ID: 33890149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric-MRI-Based Radiomics Model for Differentiating Primary Central Nervous System Lymphoma From Glioblastoma: Development and Cross-Vendor Validation.
    Xia W; Hu B; Li H; Geng C; Wu Q; Yang L; Yin B; Gao X; Li Y; Geng D
    J Magn Reson Imaging; 2021 Jan; 53(1):242-250. PubMed ID: 32864825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach.
    Suh HB; Choi YS; Bae S; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
    Eur Radiol; 2018 Sep; 28(9):3832-3839. PubMed ID: 29626238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI-Based Back Propagation Neural Network Model as a Powerful Tool for Predicting the Response to Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma.
    Liao H; Chen X; Lu S; Jin G; Pei W; Li Y; Wei Y; Huang X; Wang C; Liang X; Bao H; Liu L; Su D
    J Magn Reson Imaging; 2022 Aug; 56(2):547-559. PubMed ID: 34970824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion radiomics as a diagnostic model for atypical manifestation of primary central nervous system lymphoma: development and multicenter external validation.
    Kang D; Park JE; Kim YH; Kim JH; Oh JY; Kim J; Kim Y; Kim ST; Kim HS
    Neuro Oncol; 2018 Aug; 20(9):1251-1261. PubMed ID: 29438500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma.
    Wang G; He L; Yuan C; Huang Y; Liu Z; Liang C
    Eur J Radiol; 2018 Jan; 98():100-106. PubMed ID: 29279146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomics features to distinguish glioblastoma from primary central nervous system lymphoma on multi-parametric MRI.
    Kim Y; Cho HH; Kim ST; Park H; Nam D; Kong DS
    Neuroradiology; 2018 Dec; 60(12):1297-1305. PubMed ID: 30232517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting Double Expression Status in Primary Central Nervous System Lymphoma Using Multiparametric MRI Based Machine Learning.
    Liu G; Zhang X; Zhang N; Xiao H; Chen X; Ma L
    J Magn Reson Imaging; 2024 Jan; 59(1):231-239. PubMed ID: 37199225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI-based radiomics signature for pretreatment prediction of pathological response to neoadjuvant chemotherapy in osteosarcoma: a multicenter study.
    Chen H; Zhang X; Wang X; Quan X; Deng Y; Lu M; Wei Q; Ye Q; Zhou Q; Xiang Z; Liang C; Yang W; Zhao Y
    Eur Radiol; 2021 Oct; 31(10):7913-7924. PubMed ID: 33825032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics features based on automatic segmented MRI images: Prognostic biomarkers for triple-negative breast cancer treated with neoadjuvant chemotherapy.
    Ma M; Gan L; Liu Y; Jiang Y; Xin L; Liu Y; Qin N; Cheng Y; Liu Q; Xu L; Zhang Y; Wang X; Zhang X; Ye J; Wang X
    Eur J Radiol; 2022 Jan; 146():110095. PubMed ID: 34890936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomics-Based Machine Learning Model for Predicting Overall and Progression-Free Survival in Rare Cancer: A Case Study for Primary CNS Lymphoma Patients.
    Destito M; Marzullo A; Leone R; Zaffino P; Steffanoni S; Erbella F; Calimeri F; Anzalone N; De Momi E; Ferreri AJM; Calimeri T; Spadea MF
    Bioengineering (Basel); 2023 Feb; 10(3):. PubMed ID: 36978676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Considerable effects of imaging sequences, feature extraction, feature selection, and classifiers on radiomics-based prediction of microvascular invasion in hepatocellular carcinoma using magnetic resonance imaging.
    Dai H; Lu M; Huang B; Tang M; Pang T; Liao B; Cai H; Huang M; Zhou Y; Chen X; Ding H; Feng ST
    Quant Imaging Med Surg; 2021 May; 11(5):1836-1853. PubMed ID: 33936969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging-radiomics evaluation of response to chemotherapy for synchronous liver metastasis of colorectal cancer.
    Ma YQ; Wen Y; Liang H; Zhong JG; Pang PP
    World J Gastroenterol; 2021 Oct; 27(38):6465-6475. PubMed ID: 34720535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of MRI-based Radiomics Models in the Assessment of Hepatic Metastasis of Rectal Cancer].
    Hu SX; Yang K; Wang XR; Wen DG; Xia CC; Li X; Li ZL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 52(2):311-318. PubMed ID: 33829708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of recurrence of ischemic stroke within 1 year of discharge based on machine learning MRI radiomics.
    Liu J; Wu Y; Jia W; Han M; Chen Y; Li J; Wu B; Yin S; Zhang X; Chen J; Yu P; Luo H; Tu J; Zhou F; Cheng X; Yi Y
    Front Neurosci; 2023; 17():1110579. PubMed ID: 37214402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment Multiparametric MRI-Based Radiomics Analysis for the Diagnosis of Breast Phyllodes Tumors.
    Ma X; Gong J; Hu F; Tang W; Gu Y; Peng W
    J Magn Reson Imaging; 2023 Feb; 57(2):633-645. PubMed ID: 35657093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrative non-invasive malignant brain tumors classification and Ki-67 labeling index prediction pipeline with radiomics approach.
    Zhang L; Liu X; Xu X; Liu W; Jia Y; Chen W; Fu X; Li Q; Sun X; Zhang Y; Shu S; Zhang X; Xiang R; Chen H; Sun P; Geng D; Yu Z; Liu J; Wang J
    Eur J Radiol; 2023 Jan; 158():110639. PubMed ID: 36463703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and external validation of a multiparametric MRI-based radiomics model for preoperative prediction of microsatellite instability status in rectal cancer: a retrospective multicenter study.
    Li Z; Zhang J; Zhong Q; Feng Z; Shi Y; Xu L; Zhang R; Yu F; Lv B; Yang T; Huang C; Cui F; Chen F
    Eur Radiol; 2023 Mar; 33(3):1835-1843. PubMed ID: 36282309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI-based radiomics for pretreatment prediction of response to concurrent chemoradiotherapy in locally advanced cervical squamous cell cancer.
    Zhang X; Zhang Q; Chen Y; Wang S; Zhang J; An J; Xie L; Yu X; Zhao X
    Abdom Radiol (NY); 2023 Jan; 48(1):367-376. PubMed ID: 36222869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.